When Diagnosed With Cervical Cancer, Single Mom Turns to Advocacy — for Herself, Her Children and Other Survivors
In this episode of the “Cancer Horizons” podcast, a cervical cancer survivor and advocate explains how she navigated being given six to 24 months to live as a single mother of three children and no health insurance.
A cancer diagnosis may be earth-shattering, no matter the stage or cancer type. But what happens when you’re a young mother of three children, without a current option for health insurance, and you’re given six to 24 months to live?
In honor of cervical cancer awareness month, CURE® spoke with cancer survivor Aisha McClellan in this episode of the “Cancer Horizons” podcast. McClellan shared how she advocated strongly for not only herself, but her children’s futures, and was able to achieve remission — which she has been in for four and a half years now. She also described how her journey led her to becoming an advocate for others through the SHARE organization.
“And so (at) 32 years old, again, a single mother of three, I was at a loss,” McClellan said. “I mean, it was devastating. And I just kind of had my big cry, and I had my breakdown, and I (thought) this isn't really good work for me. I didn't have any viable options of anybody to take care of my kids. I knew that I had no choice but to figure this out.”
For more news on cancer updates, research and education, don’t forget to subscribe to CURE®’s newsletters here.
Patients With Cervical Cancer Survivor Can Thrive With Social Support
January 31st 2024“When you have support, you have answers to some of your unknowns and that can provide stability and ease in anxiety and depression, and truly propel you into thriving,” a cervical cancer survivor and advocate tells CURE®.
Read More
Cannabis Talks During Cancer, Cardiometabolic Comorbidities and Current Research
March 4th 2024In addition to a breakthrough therapy designation for a lung cancer drug, this week we’ll be talking a lot about additional side effects and health conditions that may come with a cancer diagnosis, and how to manage them.
Listen
Tivdak Confers 30% Reduction in Mortality Risk in Cervical Cancer
October 22nd 2023A 30% reduction in the risk of death versus. investigator’s choice of chemotherapy as second or third line therapy was concluded when Tivdak was combined for the treatment of recurrent or metastatic cervical cancer with disease progression on doublet chemotherapy.
Read More
